1,320
Participants
Start Date
March 7, 2025
Primary Completion Date
October 13, 2025
Study Completion Date
October 13, 2025
mRNA-1083 Composition 1 Dose A Lot A
Sterile liquid for injection
mRNA-1083 Composition 1 Dose A Lot B
Sterile liquid for injection
mRNA-1083 Composition 1 Dose B
Sterile liquid for injection
mRNA-1083 Composition 1 Dose C
Sterile liquid for injection
mRNA-1083 Composition 2 Dose A
Sterile liquid for injection
mRNA-1083 Composition 2 Dose B
Sterile liquid for injection
mRNA-1083 Composition 3 Dose A
Sterile liquid for injection
mRNA-1083 Composition 3 Dose B
Sterile liquid for injection
Influenza Vaccine
Sterile liquid for injection
COVID-19 Vaccine
Sterile liquid for injection
Investigational Influenza Vaccine
Sterile liquid for injection
Investigational COVID-19 Vaccine Lot A
Sterile liquid for injection
Investigational COVID-19 Vaccine Lot B
Sterile liquid for injection
DM Clinical Research - Philadelphia, Philadelphia
Velocity Clinical Research, Rockville, Rockville
Trial Management Associates, LLC, Wilmington
Trial Management Associates, LLC, Myrtle Beach
Clinical Research Atlanta (Headlands), Stockbridge
Velocity Clinical Research, Cincinnati, Mt. Auburn, Cincinnati
Velocity Clinical Research, Cincinnati, Springdale, Cincinnati
DM Clinical Research - Detroit, Southfield
DM Clinical Research - Chicago, Melrose Park
Velocity Clinical Research, Norfolk, Norfolk
Velocity Clinical Research, Lafayette, Lafayette
DM Clinical Research - Bellaire, Houston
DM Clinical Research - Tomball, Tomball
Velocity Clinical Research, Boise, Meridian
Headlands Research Scottsdale, Scottsdale
Artemis Research (Headlands), San Diego
DM Clinical Research - Boston, Brookline
ModernaTX, Inc.
INDUSTRY